Advertisement
To participate in the conference call, please dial (800) 357-0498 forinternational callers dial (850) 429-1388 (access code 9294#) five to tenminutes prior to the initiation of the teleconference. If you are unable tolisten to the live broadcast a replay of the call will be available startingon July 9, 2008 two hours following the end of the call until July 16, 2008 at11:59 p.m. Eastern Time. For the U.S. replay, please dial (800) 695-0697 forinternational callers dial (402) 220-1472 (access code 9294#).
Advertisement
About ULURU Inc.:
ULURU Inc. is an emerging specialty pharmaceutical company focused on thedevelopment of a portfolio of wound management, plastic surgery and oral careproducts to provide patients and consumers improved clinical outcomes throughcontrolled delivery utilizing its innovative transmucosal delivery system andHydrogel Nanoparticle Aggregate technology. For further information aboutULURU Inc., please visit our website at http://www.uluruinc.com.
This press release contains certain statements that are forward-lookingwithin the meaning of Section 27a of the Securities Act of 1933, as amended.These statements are subject to numerous risks and uncertainties, includingbut not limited to the risk factors detailed in the Company's Annual Report onForm 10-KSB for the year ended December 31, 2007 and other reports filed by uswith the Securities and Exchange Commission.Contact: Company Kerry P. Gray President & CEO Terry K. Wallberg Vice President & CFO (214) 905-5145
SOURCE ULURU Inc.
